Doctor profile · Federal record
Dr. Namrata Shah, M.D.
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Munster, IN
- NPI 1548460173
- Accepts Medicare
- 24 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1950 45Th St Ste 200
Munster, IN 463213958
(219) 912-3376
fax (219) 529-6267
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- September 29, 2022
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Indiana #01064342A · Illinois #036-115856
- Medicaid
- IN #200880790A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1548460173. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,686
Distinct HCPCS
10
Medicare allowed
$98,354
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 614 | 86 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 297 | 177 | $85 | |
17000 |
Destruction of precancer skin growth, 1 growth | 223 | 121 | $52 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 102 | 102 | $104 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 101 | 77 | $121 | |
11102 |
Biopsy of related skin growth, first growth | 74 | 71 | $80 | |
17110 |
Destruction of skin growth, 1-14 growths | 62 | 44 | $101 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 45 | 44 | $53 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 35 | 35 | $157 | |
11104 |
Punch biopsy, first skin growth | 25 | 25 | $114 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 122. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$941
Transactions
45
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 10 | $160.44 | |
| Amgen Inc. | 5 | $120.48 | |
| Novartis Pharmaceuticals Corporation | 6 | $110.41 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $99.77 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $60.06 | |
| Incyte Corporation | 2 | $56.07 | |
| GENZYME CORPORATION | 2 | $46.87 | |
| PFIZER INC. | 3 | $42.64 | |
| Lilly USA, LLC | 2 | $39.72 | |
| Kerecis Limited | 1 | $37.39 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $34.00 | |
| Arcutis Biotherapeutics, Inc. | 2 | $31.26 | |
| Dermavant Sciences, Inc. | 1 | $23.94 | |
| UCB, Inc. | 1 | $17.56 | |
| Organogenesis Inc. | 1 | $16.81 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
607
Patients
298
Total drug cost
$146,098
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 185 | 83 | $3,869 |
| Triamcinolone Acetonide | Generic | 120 | 82 | $1,286 |
| Clobetasol Propionate | Generic | 98 | 49 | $8,170 |
| Doxycycline Monohydrate | Generic | 37 | 14 | $1,551 |
| Mupirocin | Generic | 30 | 27 | $338 |
| Clindamycin Phosphate | Generic | 22 | 16 | $798 |
| Hydrocortisone | Generic | 22 | 15 | $92 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 19 | 0 | $292 |
| Metronidazole | Generic | 18 | 0 | $1,399 |
| Otezla (Apremilast) | Brand | 16 | 0 | $124,576 |
Frequently asked questions
What is Dr. Namrata Shah's medical specialty?
Dr. Namrata Shah practices Dermatology Physician in Munster, IN.
Where does Dr. Namrata Shah practice?
Dr. Namrata Shah practices at 1950 45Th St Ste 200, Munster, IN 463213958. Office phone: 2199123376.
What is Dr. Namrata Shah's NPI?
Dr. Namrata Shah's National Provider Identifier (NPI) is 1548460173, issued by NPPES.
Does Dr. Namrata Shah accept Medicare assignment?
Yes. Dr. Namrata Shah accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Namrata Shah commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.